Urate oxidase

Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Oxidoreductase

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S252300, C435S320100, C536S023200

Reexamination Certificate

active

07056713

ABSTRACT:
The present invention relates, in general, to urate oxidase (uricase) proteins and nucleic acid molecules encoding same. In particular, the invention relates to uricase proteins which are particularly useful as, for example, intermediates for making improved modified uricase proteins with reduced immunogenicity and increased bioavailability.

REFERENCES:
patent: 3613231 (1971-10-01), Bergmeyer et al.
patent: 4179337 (1979-12-01), Davis et al.
patent: 4460683 (1984-07-01), Gloger et al.
patent: 4766106 (1988-08-01), Katre et al.
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4917888 (1990-04-01), Katre et al.
patent: 5286637 (1994-02-01), Veronese et al.
patent: 5382518 (1995-01-01), Caput et al.
patent: 5428128 (1995-06-01), Mensi-Fattohi et al.
patent: 5541098 (1996-07-01), Caput et al.
patent: 5612460 (1997-03-01), Zalipsky
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5653974 (1997-08-01), Hung et al.
patent: 5880255 (1999-03-01), Delgado et al.
patent: 5919455 (1999-07-01), Greenwald et al.
patent: 6201110 (2001-03-01), Olsen et al.
patent: 6245901 (2001-06-01), von der Osten
patent: 6576235 (2003-06-01), Williams et al.
patent: 279 486 (1990-06-01), None
patent: 09154581 (1997-06-01), None
patent: WO 94/19007 (1994-09-01), None
patent: WO 00/07629 (2000-02-01), None
patent: WO 01/59078 (2001-08-01), None
Miura, S., et al. (1994) Eur. J. Biochem. 223, 141-146.
Hershfield, M.S., et al. (1991) Proc. Natl. Acad. Sci., USA 68, 7185-7189.
Chen, R.H.L., et al. (1981) Biochim. Biophys. Acta 660, 293-298.
Ito, M. ,et al. (1992) Biochem. Biophys. Res. Comm. 187 (1), 101-107.
Yeldandi, A.V., et al. (1990) Biochem. Biophys. Res. Comm. 171 (2), 641-646.
Wu, X., et al. (1989) Proc. Natl. Acad. Sci., USA 86, 9412-9416.
Wu, X., et al. (1992) J. Mol. Evol. 34, 78-84.
Conley, T.G., et al. (1980) Biochem. J. 187, 727-732.
Henney, C.S., et al. (1968) New Eng. J. Med. 178(21), 1144-1146.
Hershfield, M.S., et al. (1991) Proc. Natl. Acad. Sci., USA 88, 7185-7189.
Chua et al, “Use of polyethylene glycol-modified uricase (PEG-uricase) to treat hyperuricemia in a patient with non-Hodgkin lymphoma”, Annals of Internal Medicine, New York, NY; Jul. 15, 1988, pp. 114-117.
Davis et al, “Hypouricaemic Effects of Polyethyleneglycol Modified Urate Oxidase” Lancet The, Lancet Limited, London, GB, Aug. 8, 1981, pp. 281-283.
Savoca, K.V., et al., “Induction of Tolerance in Mice by Uricase and Monomethoxypolyethylene Glycol-Modified Uricase,” Int. Archs. Allergy Appl. Immunol. 75: 58-67, S. Karger Medical and Scientific Publishers (1984).
Suzuki, H., and Verma, D.P.S., “Soybean Nodule-Specific Uricase (Nodulin-35) Is Expressed and Assembled into a Functional Tetrameric Holoenzyme inEscherichia coli,” Plant Physiol. 95: 384-389, American Society of Plant Physiologists (1991).
Alvares, K., et al., “Rat urate oxidate produced by recombinant baculovirus expression: Formation of peroxisome crytalloid core-like structure,” Proc. Natl. Acad. Sci. USA 89: 4908-4912 (1992).
Calicet, P., et al., “Biopharmaceutical Properties of Uricases Conjugated to Neutral and Amphiphilic Polymers,” Bioconj. Chem. 10: 638-646 (Jun. 1999).
Kelly, S.J., et al., “Diabetes Insipidus in Uricase-Deficient Mice: A model for Evaluating Therapy with Poly (Ethylene Glycol) -Modified Uricase,” J. Am. Soc. Nephrol. 12: 1001-1009 (2001).
Mountain View Pharmaceuticals, Inc., “PURICASE®,” U.S. Trademark Registration No. 2,246,623 (report obtained from U.S. Trademark Electronic Search System (TESS), (Apr. 15, 2003).
R&D Focus Drug News (DataStar File IPNR/IPNA), Accession No. 1998:2984 DRUGNL, “PEG-uricase BioTechnology General, Duke University, Mountain View licensing agreement,” (Aug. 24, 1998).
Abuchowski, A., et al., “Effect of Covalent Attachment of Polyethylene Glycol on Immunogenicity and Circulating Life of Bovine Liver Catalase”, Journal of Biological Chemistry 252: 3582-3586 (1977).
Burnham, N., “Polymers for Delivering Peptides and Proteins”, American Journal of Hospital Pharmacy,51: 210-218 (1994).
Davis, F.F., et al., “Enzyme-Polyethylene Glycol Adducts; Modified Enzymes with Unique Properites”, Enzyme Engineering 4: 169-173 (1978).
Fuertges, F., et al., “The Clinical Efficacy of Poly(Ethylene Glycol)-Modified Proteins,” J. Controlled Release, 11: 139-148 (1990).
Braun, A., and Alsenz, J., “Development and Use of Enzyme-Linked Immunosorbent Assays (ELISA) for the Detection of Protein Aggregates in Interferon-Alpha (IFN-α) Formulations,” Pharm. Res. 14: 1394-1400 (Oct. 1997).
Braun, A., et al., “Protein Aggregates Seem to Play a Key Role Among the Parameters Ingluencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic Mice,” Pharm. Res. 14: 1472-1478 (Oct. 1997).
Colloc'h, N., et al., “Crystal Structure of the protein drug urate oxidase-inhibitor complex at 2.05 Å resolution,” Nature Struct. Biol. 4: 947-952 (Nov. 1997).
Kito, M., et al., “A Simple and Efficient Method for Preparation of Monomethoxypolyethylene Glycol Activated with p-Nitrophenylchloroformate and Its Application to Modification of L-Asparaginase,” J. Clin. Biochem. Nutr. 21: 101-111 (1996).
Kunitani, M., et al., “Classical light scattering quantitation of protein aggregates: off-line spectroscopy versus HPLC detection,” J. Pharm. Biomed. Anal. 16: 573-586 (Dec. 1997).
Lee, C.C., et al., “Generation of cDNA Probes Directed by Amino Acid Sequence: Cloning of Urate Oxidase,” Science 239: 1288-1291 (1988).
Mahler, H.R., et al., “Studies on Uricase: I. Preparation, Purification, and Properties of a Cuproprotein,” J. Biol. Chem. 216: 625-641 (1955).
Montalbini, P., et al., “Uricase from leaves: its purification and characterization from three different higher plants,” Planta 202: 277-283 (Jul. 1997).
Moore, W.V., and Leppert, P., “Role of Aggregated Human Growth Hormone (hGH) in Development of Antibodies to hGH,” J. Clin. Endocrinol. Metab. 51: 691-697 (1980).
Osman, A.M., et al., “Liver Uricase in Camelus dromedarius: Purification and Properties,” Comp. Biochem. Physiol 94B: 469-474 (1989).
Palleroni, A.V., et al., “Interferon Immunogenicity: Preclinical Evaluation of Interferon-α2a,” J. Interferon Cytokine Res. 17 (Suppl 1): S23-S27 (Jul. 1997).
Porstmann, B., et al., “Comparison of Chromogens for the Determination of Horseradish Peroxidase as a Marker in Enzyme Immunoassay,” J. Clin. Chem. Clin. Biochem. 19: 435-439 (1981).
Fam, A.G., “Strategies and Controversies in the Treatment of Gout and Hyperuricaemia,” Clinical Rheumatology International Practice and Research 4: 177-192 (1990).
Hande, K.R., et al., “Severe Allupurinol Toxicity,” American Journal of Medicine 76: 47-56 (1984).
Hedlund, L.W., et al., “Magnetic Resonance Microscopy of Toxic Renal Injury Induced by Bromoethylamine in Rats,” Fundamental and Applied Toxicology 16: 787-797 (1991).
Kahn, K., et al., “Kinetic Mechanism and Cofactor Content of Soybean Root Nodule Urate Oxidase,” Biochemistry 36: 4731-4738 (1997).
Kunitani, M., et al., “On-Line Characterization of Polyethylene Glycol-Modified Proteins,” Journal of Chromatography 588: 125-137 (1991).
Leach, M., et al., “Efficacy of Urate Oxidase (Uricozyme) in Tumor Lysis Induced Urate Nephropathy,” Clinical and Laboratory Haematology 20: 169-172 (1998).
Legoux, R., et al., “Cloning and Expression inEscherichia coliof the Gene EncodingAspergillus flavusUrate Oxidase,” Journal of Biological Chemistry 267: 8565-8570 (1992).
Mahmoud, H.H., et al., “Advances in the Management of Malignancy-Associated Hyperuricaemia,” British Journal of Cancer 77 (Supplement 4): 18-20 (1998).
Nishimura, H., et al., “Improved Modification of Yeast Uricase wi

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Urate oxidase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Urate oxidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Urate oxidase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3686195

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.